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Abstract  34 
 35 
Crumbs3 (CRB3) is a component of epithelial junctions that has been implicated in 36 
apical-basal polarity, apical identity, apical stability, cell adhesion and cell growth. CRB3 37 
undergoes alternative splicing to yield two variants: CRB3a and CRB3b. Here, we describe 38 
novel data demonstrating that as with previous studies on CRB3a, CRB3b also promotes the 39 
formation of tight junctions. However, significantly we demonstrate that the 4.1-ezrin-40 
radixin-moesin (FERM) binding motif (FBM) of CRB3b is required for CRB3b functionality 41 
and that ezrin binds to the FBM of CRB3b. Furthermore, we show that ezrin contributes to 42 
CRB3b functionality and the correct distribution of tight junction proteins. We demonstrate 43 
that both CRB3 isoforms are required for the production of functionally mature tight 44 
junctions and also the localization of ezrin to the plasma membrane. Finally, we demonstrate 45 
that reduced CRB3b expression in head and neck squamous cell carcinoma (HNSCC) 46 
correlates with cytoplasmic ezrin, a biomarker for aggressive disease, and show evidence that 47 
whilst CRB3a expression has no effect, low CRB3b and high cytoplasmic ezrin expression 48 
combined may be prognostic for HNSCC.  49 
 50 
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Introduction 65 
 66 
The maintenance of cell polarity and cell-cell adhesion is essential to the functional 67 
integrity of epithelial cell layers, which line the surface of organs and assist in physiological 68 
mechanisms such as absorption and secretion (Zihni et al., 2014). Tight junctions (TJs) are 69 
apically localized intracellular structures that are part of the epithelial junctional complex. 70 
The basic structure of TJs consists of transmembrane proteins such as claudins, junctional 71 
adhesion molecules and occludins, along with regulatory proteins, which are predominantly 72 
PDZ domain containing proteins (Gonzalez-Mariscal et al., 2003; Matter and Balda, 2003b; 73 
Guillemot et al., 2008; Zihni et al., 2014). Cell polarity and cell-cell adhesion are facilitated 74 
by TJs, which allow tissues to regulate cell polarity within cells and to regulate selective 75 
permeability between cells (Anderson and Van Itallie, 2009). The barrier function of TJs was 76 
first illustrated by the retention of sphingomyelin at the apical surface of MDCK cells (Balda 77 
et al., 1996). Defects in cell polarity and cell-cell adhesion are implicated in mechanisms that 78 
range from an allergic response to inhaled antigens to metastatic cancer progression (Forster, 79 
2008; Martin and Jiang, 2009; Sawada, 2013; Georas and Rezaee, 2014). 80 
Crb is a transmembrane protein in Drosophila that mediates cell adhesion (Letizia et 81 
al., 2013). The intracellular domain of Crb contains two recognizable motifs: a FERM 82 
binding motif (FBM) and a PDZ binding motif (Richard et al., 2006). In Drosophila, Crb 83 
interacts with Expanded (Ex), a FERM domain containing protein (Ling et al., 2010; 84 
Robinson et al., 2010), via the intracellular FBM domain of Crb (Ribeiro et al., 2014), and 85 
with two FERM containing proteins, Yurt and dMoesin (Medina et al., 2002; Laprise et al., 86 
2006). In humans, there are three Crb orthologues: the most widely expressed orthologue in 87 
epithelial tissues is CRB3 (Makarova et al., 2003), where CRB3 is an important regulator of 88 
epithelial cell fate (Szymaniak et al., 2015). CRB3 has two isoforms: CRB3a, which contains 89 
a highly conserved C-terminus when compared to Drosophila Crb, while CRB3b is a splice 90 
variant resulting in a differing C-terminus. CRB3a has been shown to promote the formation 91 
of TJs and has been implicated in epithelial polarity (Roh et al., 2003; Lemmers et al., 2004; 92 
Fogg et al., 2005). The C-terminus of CRB3a contains three motifs, a FBM, a putative SH3 93 
binding region (Zarrinpar et al., 2003) and a PDZ binding motif (-ERLI) (Fogg et al., 2005). 94 
In contrast, the C-terminus of CRB3b retains the FBM but has a different C-terminus (ending 95 
–CLPI). The CRB3b isoform has been implicated in the generation of primary cilia, 96 
centrosomal localization during cell division and biochemically interacts with importin β1, 97 
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which is inhibited by active Ran-GTP (Fan et al., 2007). To date, no interactions have been 98 
reported between CRB3b and PDZ containing proteins.    99 
 Here, we describe novel data demonstrating that CRB3b promotes the formation of 100 
TJs. We demonstrate that the FBM of CRB3b is required for CRB3b functionality and that 101 
ezrin binds to the FBM of CRB3b. Furthermore, we show that ezrin contributes to CRB3b 102 
functionality and the correct distribution of TJs proteins. We demonstrate that Crb3 is 103 
required for the production of functionally mature TJs and the localization of ezrin to the 104 
plasma membrane. Finally, we demonstrate that in contrast to CRB3a, reduced CRB3b 105 
expression in human squamous cell carcinoma correlates with high cytoplasmic ezrin, a 106 
biomarker for poor survival outcome (Schlecht et al., 2012). 107 
Results 108 
 109 
CRB3a and CRB3b promote the formation of tight junctions in MCF10A cells via the 110 
FBM  111 
While CRB3a has been previously shown to promote the formation of TJs in MCF10A 112 
cells (Fogg et al., 2005; Elsum et al., 2013), little is known about the functional role of the 113 
CRB3b isoform. These isoforms show 100% homology across their extracellular domains 114 
and trans-membrane domains. The two isoforms also share the FBM, but they differ in the 115 
last 20 amino acids of the intracellular domain (ICD) (Figure 1A).  Absolute qRT-PCR was 116 
used to assess the basal levels of the different CRB3 mRNA isoforms in MCF10A cells, 117 
where CRB3a mRNA levels are higher than those of CRB3b  (Figure 1B).  118 
Next, in order to investigate the functionality of CRB3a and CRB3b in MCF10A cells, 119 
stable cell lines were generated expressing Myc-tagged CRB3a (CRB3a), FLAG-tagged 120 
CRB3b (CRB3b) and deletions of the FBM domain in both isoforms (v5-tagged 121 
CRB3a∆FBM, FLAG-tagged CRB3b∆FBM), as shown schematically in figure 1A. MCF10A 122 
cells expressing an empty vector (MCF10A-Vector) were used as control cells. Robust 123 
ectopic expression of full-length CRB3a (MCF10A-CRB3a), CRB3b (MCF10A-CRB3b), 124 
and the truncated mutants of CRB3a (MCF10A-CRB3a∆FBM) and CRB3b (MCF10A-125 
CRB3b∆FBM) was confirmed by immunoblot analysis (Figure 1C). Confocal imaging of 126 
MCF10A cells revealed that both CRB3a and CRB3b localize to the regions of cell-to-127 
cell contacts along with Ezrin (Supplementary Figure S1A). These stable cell-lines, 128 
MCF10A-Vector, MCF10A-CRB3a, MCF10A-CRB3a∆FBM, MCF10A-CRB3b and 129 
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MCF10A-CRB3b∆FBM were assessed by a series of different methodologies to investigate 130 
the potential physiological role of CRB3b and the potential role of the FBM in TJ formation.  131 
Transepithelial resistance (TER) is a means to assess the integrity of a cell monolayer 132 
and whether cells are forming junctions by assaying the electrical resistance of cells (Balda et 133 
al., 1996). Interestingly, both MCF10A-CRB3a and MCF10A-CRB3b cells demonstrated 134 
significantly increased TER when compared to the MCF10A-vector cells, indicating that both 135 
isoforms are able to promote the formation of TJs (Figure 1D; (Fogg et al., 2005; Elsum et 136 
al., 2013). However, the FBM deletion mutants of both isoforms, did not show this 137 
phenotype, with no increase in TER compared to the MCF10A-Vector cells (Figure 1D), 138 
indicating the FBM of both isoforms is required for this function. These results were 139 
supported by size-selective assessment of TJ paracellular flux using fluorescently labelled 140 
dextrans (Matter and Balda, 2003a): both MCF10A-CRB3a and MCF10A-CRB3b cells 141 
displayed decreased paracellular flux as assessed by the passage of both 4kDa-FITC and 142 
70kDa-Rhodamine dextrans when compared to the MCF10A-Vector cells (Figure 1E, 1F). In 143 
contrast, MCF10A-CRB3b∆FBM c lls were not able to restrict the passage of dextrans along 144 
the paracellular space cells and maintained paracellular flux levels that were similar to 145 
MCF10A-Vector cells (Figure 1E, 1F). MCF10A-CRB3a∆FBM cells showed an increased 146 
passage of dextrans compared to MCF10A-CRB3a, but less than MCF10A-Vector cells when 147 
using the 4kDa-FITC dextrans (Figure 1E). 148 
To further explore the role of these CRB3 isoforms and their effect on TJs, the presence 149 
of mature TJ proteins, occludin and ZO-1, were assessed. While MCF10A-Vector cells lack 150 
the ability to form tight junctions and showed no expression of occludin and ZO-1, MCF10A-151 
CRB3a cells promoted the formation of TJs in this cell type and displayed occludin and ZO-1 152 
expression, as expected from published data (Fogg et al., 2005; Elsum et al., 2013). However, 153 
MCF10A-CRB3a∆FBM showed no expression of occludin or ZO-1 under the same 154 
conditions (Figure 2A). MCF10A-CRB3b cells displayed occludin and ZO-1 continuous 155 
patterning (Figure 2A), similar to that found in mature TJs and observed in MCF10A-CRB3a 156 
cells, while MCF10A-CRB3b∆FBM cells displayed an absence of ZO-1 and occludin 157 
expression under the same conditions (Figure 2A). To quantify the amount of TJ structures in 158 
MCF10A cells, we defined a TJ structure as an unbroken ring of ZO-1 staining. Using this 159 
method, we observed that the presence of CRB3a or CRB3b greatly increased the number of 160 
TJ structures present when compared to both the empty vector and the respective FBM 161 
deletion mutants (Fig. 2B).  162 
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To assess whether there were subsequent changes in migratory behaviour, the different 163 
cell lines were also assayed using an EGF-independent Boyden chamber assay.  A serum 164 
gradient acted as a chemoattractant using a previously published protocol (Angus et al., 2012; 165 
Moleirinho et al., 2013a). Both MCF10A-CRB3a and MCF10A-CRB3b cells showed a 166 
decrease in migration when compared to MCF10A-Vector cells in a Boyden chamber assay 167 
(Figure 2C). However, MCF10A-CRB3a∆FBM and MCF10A-CRB3b∆FBM cells did not 168 
show a decrease in migration but displayed an increase in migration, as compared to 169 
MCF10A-Vector cells (Figure 2C). Therefore, we conclude that both isoforms of CRB3 170 
induce TJ formation and that this ability requires the presence of the intracellular FBM 171 
domain.  172 
 173 
Ezrin binds to the FBM of CRB3b  174 
Since deletion of the FBM resulted in abrogation of CRB3b activity, we hypothesized 175 
that this deletion had disrupted an essential protein-protein interaction. To identify proteins 176 
that bind to the FBM of CRB3b, the MCF10A-CRB3b, MCF10A-CRB3b∆FBM and 177 
MCF10A-Vector cell lines were subj cted to co-immunoprecipitation using FLAG-mAb 178 
conjugated magnetic bead followed by mass spectrometry analysis (Figure 3A). Potential 179 
interactions were identified which bound to full-length CRB3b but not to CRB3b∆FBM 180 
(Supplementary table S2). Of particular note, was the potential interaction with FERM 181 
domain-containing proteins, including ezrin (Figure 3A). To validate an interaction with 182 
ezrin, we performed co-immunoprecipitation on cell lysates from MCF10A-Vector, 183 
MCF10A-CRB3a, MCF10A-CRB3a∆FBM, MCF10A-CRB3b and MCF10A-184 
CRB3b∆FBM followed by immunoblotting using an ezrin-specific antibody. Interestingly, 185 
CRB3a-ezrin interaction was observed when full-length FLAG tagged CRB3a was 186 
expressed (MCF10A-CRB3a cells) but was not observed when V5 tagged CRB3a∆FBM 187 
was expressed (MCF10A-CRB3a∆FBM cells) (Figure 3B). A CRB3b-ezrin interaction 188 
was observed when full-length FLAG tagged CRB3b was expressed (MCF10A-CRB3b cells) 189 
but was not observed when FLAG tagged CRB3b∆FBM was expressed (MCF10A-190 
CRB3b∆FBM cells) (Figure 3C). To show this is not a general interaction with all FERM 191 
domain-containing proteins, the same co-immunoprecipitation lysates were probed for 192 
endogenous Willin/FRMD6 and Merlin/NF2 interaction. However, both endogenous 193 
Willin/FRMD6 and Merlin/NF2 did not bind to either the full length CRB3a and CRB3b or 194 
their FBM deletion mutants, under these conditions (Figure 3B, 3C). PALS1, a previously 195 
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known interaction partner of CRB3a was used to validate the co-IP, was observed to 196 
bind to both the full length CRB3a and its FBM deletion mutant (Figure 3B). Importin 197 
β1 was observed to bind to CRB3b under these same conditions (Figure 3C), in agreement 198 
with a previously reported CRB3b-importin β1 interaction (Fan et al., 2007). Interestingly, 199 
we observed that importin β1 co-immunoprecipitated with both full-length CRB3b as well as 200 
the FBM deletion mutant (Figure 3C), suggesting importin β1 binds to CRB3b in a region 201 
outside the FBM. 202 
 203 
Ezrin contributes to CRB3b functionality 204 
Having established that ezrin binds to CRB3b via its FBM, we determined whether this 205 
interaction is essential for CRB3b functionality. In order to do this, we stably expressed a 206 
short hairpin RNA targeting ezrin (shezrin) or a non-targeting scrambled control (shScr) in 207 
MCF10A-CRB3b cells. As predicted, MCF10A-CRB3b-shezrin cells displayed a significant 208 
decrease in TER when compared to MCF10A-CRB3b-shScr cells. However, the reduced 209 
expression of ezrin did not completely negate the ability of CRB3b to form TJs, as the TER 210 
reading was an intermediate reading b tween the wild type MCF10A cells (MCF10A-WT) 211 
and the MCF10A-CRB3b-shScr (Figure 4A). Successful reduction in ezrin expression in 212 
MCF10A-CRB3b-shezrin cells when compared to MCF10A-CRB3b-shScr cells, was 213 
confirmed by immunoblot analysis (Figure 4B). To demonstrate that the effects we observed 214 
were due to the depletion of ezrin, we overexpressed an empty vector control (MCF10A-215 
CRB3b-shezrin+CTR) or full-length ezrin (MCF10A-CRB3b-shezrin+ezrin) that could not 216 
be targeted by the expressed shRNA in MCF10A-CRB3b-shezrin cells by the use of a 217 
lentiviral expression system. Only the reintroduction of ezrin (MCF10A-CRB3b-218 
shezrin+ezrin) was able to rescue the observed TER phenotype, while the MCF10A-CRB3b-219 
shezrin+CTR cells displayed TER similar to the MCF10A-CRB3b-shezrin cells (Figure 4A). 220 
The successful reintroduction of ezrin was confirmed by immunoblotting (Figure 4B). 221 
In addition, MCF10A-CRB3b-shezrin cells displayed an increase in paracellular flux as 222 
assessed by 4kDa-FITC and 70kDa-Rhodamine dextrans, when compared to MCF10A-223 
CRB3b-shScr cells (Figure 4C, 4D), supporting the TER data. This phenotype was rescued 224 
by exogenous ezrin expression, MCF10A-CRB3b-shezrin+ezrin cells displayed similar levels 225 
of paracellular flux as MCF10A-CRB3b-shScr cells (Figure 4C, 4D). Expression of markers 226 
of mature TJs was also assessed. MCF10A-CRB3b-shScr cells displayed both ZO-1 and 227 
occludin continuous patterning (Figure 4E), suggesting the presence of mature TJs. In 228 
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contrast, MCF10A-CRB3b-shezrin cells displayed a disorganized pattern of both ZO-1 and 229 
occludin expression (Figure 4E). This phenotype was rescued by exogenous ezrin expression 230 
(Figure 4E). Taken together, these data suggest that ezrin contributes to CRB3b functionality 231 
by promoting the formation of mature TJs.  232 
 233 
CRB3 is essential for TJ maintenance 234 
To analyse the effects of the loss of CRB3 on TJs, we next tested the mouse mammary 235 
epithelial cell-line EPH4. Unlike MCF10A cells, which do not readily form TJs, EPH4 cells 236 
readily form TJs (Nagaoka et al., 2012; Yano et al., 2013), therefore providing a 237 
supplementary model to study the contribution of Crb3 to TJ formation. 238 
As a baseline, we assessed levels of Crb3a and Crb3b mRNA in EPH4 cells by 239 
absolute qRT-PCR: Crb3b mRNA expression was higher compared to Crb3a mRNA 240 
(Figure 5A). To investigate the effects of the loss of either Crb3 isoform expression, we 241 
designed shRNAs targeting CRB3a and CRB3b isoforms separately. Isoform specific 242 
knockdown of CRB3 in EPH4 cells was attempted and assessed by qPCR. However, the use 243 
of isoform specific shRNAs caused the up-regulation of the non-targeted CRB3 isoform 244 
(Supplementary Figure S2A, S2B). The knockdown of either Crb3a or Crb3b in EPH4 245 
cells demonstrated a modest reduction in TER (Supplementary Figure S2C) and an 246 
increased in paracellular flux as assessed by 4kDa-FITC (Supplementary Figure S2D) 247 
and 70kDa-Rhodamine dextrans (Supplementary Figure S2E), when compared to the 248 
EPH4-shScr cells. As the observed phenotypes in the single isoform knockdowns could 249 
not be singled out to be an effect of the loss of the targeted isoform or the up-regulation 250 
of the non targeted isoform, we therefore simultaneously knocked down expression of 251 
both Crb3a and Crb3b (shCrb3), and showed that both isoforms were reduced in 252 
expression by 90% in EPH4-shCrb3 cells, relative to their mRNA levels in EPH4-shScr 253 
cells (Figure 5B, 5C). EPH4-shCrb3 cells demonstrated a significant decrease in TER when 254 
compared to EPH4-shScr cells, throughout the 29-day time course (Figure 5D). EPH4-255 
shCrb3
 
cells also displayed an increase in paracellular flux as assessed by 4kDa-FITC and 256 
70kDa-Rhodamine dextrans, when compared to EPH4-shScr cells at day 5 (Figure 5E, 5F). 257 
In order to demonstrate that this phenotype was not cell-type specific, we additionally used 258 
CACO-2 cells, which have been previously used to study tight junctions (Anderson et al., 259 
1989; Li et al., 2004). Absolute qRT-PCR analysis showed that endogenous levels of CRB3a 260 
mRNA are higher compared to those of CRB3b (Figure 5G). The knockdown of CRB3 in 261 
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CACO-2 cells was performed using shRNA targeting a region common to both isoforms. 262 
Depletion of CRB3a and CRB3b mRNA in CACO-2 shCRB3 cells compared to CACO-2 263 
shscr cells was confirmed by qPCR (Figure 5H, 5I). CACO-2 shCRB3 cells showed reduced 264 
TER as compared to CACO-2 shscr cells (Figure 5J) and increased paracellular flux (Figure 265 
5K, 5L), when compared to CACO-2 shscr cells. 266 
 While EPH4-shScr cells displayed mature TJs as reflected by well-defined continuous 267 
patterning of ZO-1 around each individual cell, EPH4-shCrb3 cells displayed an impaired 268 
ability to form continuous regions of ZO-1 (Figure 6A). To quantify these TJ structures, we 269 
counted nuclei that were surrounded by a complete ZO-1 ring. We observed that in the 270 
control cells, nearly every nuclei had a continuous ZO-1 expression pattern around it whilst 271 
almost every cell with depleted Crb3 had an incomplete ZO-1 expression pattern around each 272 
nuclei (Figure 6B). EPH4-shCrb3 cells also displayed a 3-fold increase in migration in a 273 
Boyden chamber assay, when compared to EPH4-shScr cells (Figure 6C). As expected 274 
EPH4-shCrb3 cells also displayed a significant increase in scratch closure in a wound-healing 275 
assay, when compared to EPH4-shScr cells (Figure 6D). Therefore, CRB3 expression is 276 
required to maintain mature TJs in EPH4 cells.  277 
 278 
CRB3 is required for membrane localization of ezrin  279 
 Previous data has demonstrated that the intracellular distribution of ezrin changes 280 
location from the cell membrane in normal squamous mucosa to the cytoplasm in squamous 281 
carcinoma cells (Madan et al., 2006). A subsequent report showed that high levels of 282 
cytoplasmic ezrin in head and neck squamous cell carcinoma (HNSCC) correlate with poor 283 
clinical outcome for patients, along with reduced CRB3 mRNA expression (Schlecht et al., 284 
2012). Given these results, we hypothesized that a decrease in CRB3 expression would cause 285 
a shift in the subcellular localization of ezrin. To test this hypothesis, we used the EPH4-286 
shScr and the EPH4-shCrb3 cells, which were grown on coverslips to allow cell-cell contact. 287 
EPH4-shScr cells displayed ezrin localization at the plasma membrane at regions of cell-cell 288 
contact, while EPH4-shCrb3 cells displayed a shift in the localization of ezrin from the 289 
membrane to the cytoplasm (Figure 7A). Using line intensity scan profiles of lines drawn 290 
from nuclei to nuclei, a peak that corresponds to the membrane accumulation of ezrin in the 291 
control cells, that is not present within the EPH4-shCrb3 cells is observed, suggesting a 292 
change in ezrin subcellular localization (Figure 7B).  293 
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In order to determine whether the reduced expression of CRB3b correlates with 294 
cytoplasmic ezrin in a more physiological and clinical context, HNSCC tissue and 295 
corresponding normal adjacent healthy tissue were assessed by immunohistochemistry using 296 
anti-CRB3b and anti-ezrin antibodies followed by DAB to detect expression of either 297 
endogenous CRB3b or ezrin. Twenty-five cases of squamous cell carcinoma tissue and 298 
corresponding normal adjacent healthy tissue were selected based on cytoplasmic ezrin 299 
expression levels in the squamous carcinoma cells (Schlecht et al., 2012). In normal 300 
squamous epithelium, both CRB3b and ezrin were expressed in the stratum spinosum (n=21). 301 
Expression of CRB3b was observed at the cell membrane (n=15), and also occasionally peri-302 
nuclear (n=15) (Figure 7C (aii, aiii)) and within the nucleus (n=11) (Figure 7C (aiii)). 303 
Similarly CRB3b was observed to be present at cell-to cell junctions and in the nucleus 304 
of MCF10A cells (Supplementary Figure S1B). Notably, CRB3b was strongly expressed in 305 
the stratum spinosum but little or no expression was observed within the stratum basale in 306 
normal tissue (n=21) (Figure 7C (ai, aii, aiii)). In adjacent serial sections, expression of ezrin 307 
was localized at the cell membrane in the stratum spinosum and stratum basale (n=19) 308 
(Figure 7C (bi, bii, biii)). In contrast, in squamous cell carcinoma tissue, CRB3b expression 309 
was absent in the majority of cells (n=18) (Figure 7C (ci, cii, ciii)) or displayed heterogeneity 310 
in expression throughout the tumour but never at the cell membrane (n=8) (Figure 7C (ci)). 311 
However, high cytoplasmic ezrin was observed within squamous carcinoma cells with little 312 
or no expression at the cell membrane (n=16) (Figure 7C (di, dii, diii)). To address the 313 
specificity of the antibody used to detect CRB3b, validation by immunoblotting was 314 
performed, showing detection of CRB3b but not of CRB3a (Supplementary Figure S3). 315 
Therefore, we conclude that reduced CRB3b expression correlates with an increase in 316 
cytoplasmic ezrin within HNSCC.  317 
 318 
High CRB3b, but not CRB3a, improves high cytoplasmic ezrin survival prediction in 319 
HNSCC 320 
A significant association between increased cytoplasmic ezrin and poor cancer 321 
survival in HNSCC has previously been reported (Schlecht et al., 2012). Therefore, we 322 
assessed whether CRB3 expression added prognostic information to cytoplasmic ezrin status. 323 
CRB3 expression was measured using the Illumina HumanHT-12 v3 Expression BeadChip 324 
platform from total RNA extracted from 55 fresh, frozen primary HNSCC tumour samples 325 
that were assessed for ezrin protein expression (Schlecht et al., 2012). Three Illumina probes 326 
detected CRB3; one targeting a precursor RNA of both CRB3a and CRB3b isoform variants 327 
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(ILMN_2405680), one targeting CRB3b (ILMN_1723092), and one targeting CRB3a 328 
(ILMN_1793932).  329 
Differences in cancer survival probabilities were estimated for each CRB3 probe 330 
using Kaplan-Meier analyses and Log-rank tests comparing HNSCC stratified by CRB3 331 
status defined using median cut-off levels in CRB3 RNA expression in the tumour (Figure 332 
8A). Poorer survival outcome was observed with decreased CRB3 expression as measured 333 
using probes that detected CRB3b RNA (ILMN_1723092; Figure 8A(i), and 334 
ILMN_2405680; Figure 8A(ii), but not for the CRB3a variant (ILMN_1793932; Figure 335 
8A(iii)). Poorer survival outcome was observed in patients with tumours with high levels 336 
of cytoplasmic ezrin (Figure 8A(iv)). Compared to patients with tumours displaying high 337 
cytoplasmic ezrin and CRB3 expression, patients with tumours displaying low CRB3b RNA 338 
expression (ILMN_2405680 p=0.03; Figure 8B(i) and, ILMN_1723092 log-rank p=0.04; 339 
Figure 8B(ii)) and high cytoplasmic protein ezrin expression had significantly poorer cancer 340 
survival outcome, but patients with tumours displaying low CRB3a RNA expression 341 
(ILMN_1793932 p=0.45; Figure 8B(iii)) and high cytoplasmic protein ezrin expression did 342 
not.  343 
 344 
 345 
 346 
Discussion 347 
Tight junctions (TJs) influence both cell polarity and cell-cell adhesion and are 348 
important for epithelial tissue physiology (Shin et al., 2006; Matter and Balda, 2007). 349 
MCF10A cells have been used by numerous groups to test the ability of proteins to promote 350 
the formation of TJs, due to the absence of mature TJs in these cells (Fogg et al., 2005; Elsum 351 
et al., 2013; Rousseau et al., 2013). While previous studies on the CRB3b isoform have 352 
implicated it in the generation of primary cilia, in cell division and as an interaction partner 353 
with importin β1 in a Ran-GTP dependent fashion (Fan et al., 2007), here we show that 354 
CRB3b promotes the formation of TJs in MCF10A cells. This occurs even though the C-355 
terminus of CRB3b lacks a conserved PDZ binding motif and a conserved SH3 domain, 356 
when compared to the C-terminus of CRB3a. Functionally, CRB3b expression increases TER 357 
and reduces paracellular flux, and this is dependent on the presence of the FBM. CRB3b 358 
expression also induces both ZO-1 and occludin expression similar to published data in 359 
MCF10A cells expressing the CRB3a isoform (Fogg et al., 2005; Elsum et al., 2013). The 360 
absence of the SH3 domain and the PDZ binding motif in CRB3b suggests that the FBM of 361 
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CRB3b is indispensable for the formation of mature TJs. Our data suggest that both isoforms 362 
of CRB3 are able to promote the formation of TJs, and that the FBM is required for this 363 
function in both Crb3a and CRB3b.  364 
Surprisingly, no proteins from known polarity complexes of CRB3-PALS1-PATJ or PAR6-365 
PAR3-aPKC were identified by mass spectrometry in our CRB3b immunoprecipitation, 366 
suggesting that this isoform of CRB3 may use a mechanism for mature TJ formation 367 
independent of these protein complexes. This is supported by data showing that PALS1 and 368 
PAR6 bind to the “ERLI” PDZ binding motif in CRB3a (Lemmers et al., 2004; Fogg et al., 369 
2005; Elsum et al., 2013). In contrast with Drosophila Crb, which interacts with Ex (Ling 370 
et al., 2010; Robinson et al., 2010), we find that under physiologically relevant 371 
conditions, mammalian CRB3a and CRB3b bind to ezrin and not to Willin/FRMD6, the 372 
reported human homologue of Ex (Hamaratoglu et al., 2006; Angus et al., 2012). Our 373 
study has been unable to replicate the interaction between the mammalian orthologues 374 
of Crb and Ex, however this could be due to the difference between the sizes and 375 
structural conformations of Ex (1429 aa) and Willin/FRMD6  (614 aa) (Moleirinho et 376 
al., 2013b). Further, we show that the FERM domain protein ezrin interacts with the FBM of 377 
CRB3b and importantly reduced ezrin expression results in diminished TER and increased 378 
paracellular flux in CRB3b expressing cell monolayers. Similarly, we find no interaction of 379 
CRB3 with Merlin/NF2. Our data suggest that the FBM of Crb/CRB3 selectively binds 380 
FERM domain containing proteins, but there are fundamental differences between 381 
Drosophila and mammals. Recent work has suggested that the Drosophila Crb-C-terminus 382 
is able to crystalize with the dMoesin FERM domain, where the FBM of Crb interacts with 383 
the F3 lobe of the dMoesin FERM domain (Wei et al., 2015). The same group also 384 
demonstrated that the interaction between the Drosophila Crb-C-terminus and PALS1 via the 385 
PDZ motif is a much stronger interaction than Crb-dMoesin (Li et al., 2014). Two binding 386 
motifs may have allowed for the evolution of gain of function activities in some tissues (Le 387 
Bivic, 2013), and CRB3b may have evolved to allow for a more stable FBM interaction as 388 
compared to a PDZ interaction. Nevertheless, we would argue that the FBM of both isoforms 389 
is required for the formation of TJs.  390 
In MCF10A cells, both CRB3 isoforms are able to promote the formations of TJ 391 
junctions and colocalize with ezrin at cell-to-cell contacts. The precise mechanism of 392 
how CRB3 and ezrin promote the formation of TJs is currently unknown. One of the 393 
technical issues encountered during knocking down the individual isoforms of Crb3 in 394 
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EPH4 cells was the resultant up regulation of the non-targeted isoform. However, the 395 
single knockdowns of either Crb3a or Crb3b demonstrated that TJ formation was 396 
affected when assessed by TER and dextran diffusion, suggesting functional 397 
redundancy between Crb3a and Crb3b. It is important to note that due to up regulation 398 
of the non-targeted isoform no firm conclusions can be made as to the precise roles of 399 
the individual isoforms of Crb3 in the formation of TJs.  Data from the double 400 
knockdown of Crb3 in EPH4 demonstrated that both isoforms are required for the 401 
formation of TJs and the membrane localization of ezrin. 402 
Down-regulation or loss of function of Crb3 contributes to tumour progression (Karp 403 
et al., 2008). When immortalized baby mouse kidney cells were injected into nude mice, 404 
tumours formed which could be reintroduced into tissue culture. Further analysis revealed 405 
that these tumour derived cell lines (TDCL) harboured a loss of Crb3 and they lost the ability 406 
to form epithelial junctions when compared to the parent cells. The re-introduction of Crb3a 407 
into these TDCLs caused the cells to regain their epithelial phenotype and regain contact 408 
inhibited growth, reduced migration and allowed for the formation of TJs (Karp et al., 2008). 409 
This suggests that CRB3 acts as a tumour suppressor by promoting epithelial characteristics. 410 
Interestingly, CRB3a and ezrin are both considered being apical determinants in cell culture 411 
models (Makarova et al., 2003; Lemmers et al., 2004; Viswanatha et al., 2012; Mojallal et al., 412 
2014). Ezrin interacts with PALS1 (Cao et al., 2005), which also binds to the -ERLI PDZ 413 
binding motif in CRB3a (Lemmers et al., 2004; Fogg et al., 2005; Elsum et al., 2013). 414 
Recently, in vitro GST binding studies have suggested the FBM of CRB3a interacts with the 415 
FERM domain of ezrin (Whiteman et al., 2014), although no functional studies were carried 416 
out. However, this raises the possibility that mammalian CRB3 isoforms may dimerize via 417 
FBM-mediated ezrin binding, since we show that both CRB3a and CRB3b binds ezrin. It is 418 
interesting that the intestines of Crb3
-/-
 mouse (Whiteman et al., 2014) share defect 419 
similarities with those of the Ezr
-/-
 mouse (Casaletto et al., 2011), suggesting that they are 420 
involved in the same processes, supporting this notion. Paradoxically, ezrin may contribute to 421 
the tumour suppressive function of CRB3 under normal physiological conditions, and may 422 
only display oncogenic properties when this interaction is disrupted (Karp et al., 2008). 423 
Recent work from the Varelas Lab has demonstrated that Crb3 controls cell fate by the 424 
retention of YAP in the cytoplasm allowing for the differentiation of airway epithelial 425 
cells (Szymaniak et al., 2015). The loss of Crb3 resulted in the nuclear localization of 426 
YAP in lung epithelial airway progenitor cells resulting in the failure of these cells to 427 
differentiate into mature airway epithelial cells, which also exhibited the loss of 428 
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apicobasal polarity and TJs (Szymaniak et al., 2015). Although the expression of YAP in 429 
our HNSCC cohort has not been investigated, high expression of nuclear YAP has been 430 
reported in HNSCC (Ge et al., 2011).  431 
Interestingly, the subcellular localization of ezrin has been implicated with 432 
aggressiveness in HNSCC (Schlecht et al., 2012). In our cohort of HNSCC, we observed that 433 
ezrin localized to the cytoplasm of the carcinoma cells, which correlated with poor outcomes 434 
for the patients (Schlecht et al., 2012). In this same cohort, we now show high CRB3b 435 
expression in normal mucosa and reduced CRB3b expression in squamous cell carcinoma, 436 
which supports the idea that the loss of CRB3 plays a role in epithelial tumours. While the 437 
expression levels of CRB3a did not stratify the outcome for patients in our study, high levels 438 
of CRB3b mRNA correlated with increased clinical survival outcome, indicating that CRB3b 439 
and significantly not CRB3a, is correlated with clinical outcome. Also, combined CRB3b 440 
mRNA expression and cytoplasmic ezrin protein expression data was able to stratify patient 441 
survival outcome better than either CRB3b mRNA expression or cytoplasmic ezrin protein 442 
expression alone.   443 
Loss of CRB3b may be a pot ntial mechanistic explanation for high cytoplasmic 444 
ezrin. Intense cytoplasmic ezrin has been observed and may predict poor survival in 445 
colorectal cancer, endometrioid carcinomas, uterine cervical cancer and pancreatic ductal 446 
adenocarcinomas (Elzagheid et al., 2008; Park et al., 2010; Kong et al., 2013). With 447 
cytoplasmic ezrin being reported in a variety of carcinomas, it would be relevant to determine 448 
if the loss of CRB3b correlated with this localization shift within these subsets of tumours. 449 
Currently one study has reported loss of CRB3 expression in human tumours, in which in 450 
clear cell renal cell carcinoma patients, low CRB3 expressing tumours correlate with a poor 451 
clinical outcome (Mao et al., 2015). Our data support reported literature describing CRB3 452 
tumour suppressive behaviour and raises the question of whether CRB3 loss is common in 453 
cancers that have high cytoplasmic ezrin. Our data suggest that reduced or absent CRB3b 454 
expression should be investigated as a prognostic marker in squamous cell carcinoma.  455 
In normal squamous mucosa, CRB3b showed reduced expression in basal and 456 
parabasal layers which are responsible for populating the stratum spinosum (Birajdar et al., 457 
2014). Our CRB3b expression data in the stratum spinosum are strikingly similar to the 458 
expression patterns of differentiation markers involucrin, SPRR2 and SPRR3 observed in 459 
buccal mucosa (Gibbs and Ponec, 2000) and to expression patterns of TJ proteins ZO-1, 460 
Claudin-1, Claudin-4 and Claudin-7 in buccal mucosa and lip epithelium (Lourenco et al., 461 
2010). This suggests that CRB3b is preferentially expressed in maturing and differentiated 462 
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cells that form TJs, and these cells display protective characteristics in the uppermost layers 463 
of oral squamous epithelia. The reasons for CRB3b nuclear localization in the MCF10A 464 
cells and HNSCC tumours are unclear at present.  Previous literature and data from 465 
this study shows the CRB3b interaction with Importin β1, which is responsible for both 466 
nuclear and ciliary import of proteins (Kee and Verhey, 2013). One possible explanation 467 
for this nuclear localization of CRB3b in both cell culture and HNSCC tumours could 468 
be the occurrence of high levels of nuclear import of proteins dependent on a Ran-469 
GTP/Ran-GDP gradient. For example nuclear EGFR is observed in HNSCC p16 470 
negative tumours and this nuclear transport can be facilitated by Importin β1, (Lo et 471 
al., 2006; Husain et al., 2012). In our cohort of highly aggressive and invasive tumours, the 472 
reduced levels of CRB3b may result in reduced epithelial characteristics, allowing for the 473 
tumour cells to be more proliferative. Indeed, reduced expression of TJ proteins occurs in the 474 
invasive fronts of oral squamous cell carcinomas and there is no expression of TJ proteins in 475 
poorly differentiated tumours (Lourenco et al., 2010). This loss of TJ proteins has also been 476 
observed in breast cancer (Martin et al., 2004). As our model suggests that CRB3b is 477 
able to promote the formation of TJs, the loss of CRB3b in HNSCC may result in the 478 
inability of the tumour cells to form and maintain TJs allowing for the delamination of 479 
tumour cells from an epithelial sheet thereby undergoing single cell mediated invasion 480 
rather than collective invasion. The absence of cell junctions is a classical feature of 481 
amoeboid/mesenchymal invasion while the presence of cell junctions is widely observed 482 
in collective invasion of tumour cells (Friedl et al., 2012). In oral squamous cell 483 
carcinoma, poor survival outcomes correlate with a pattern of invasion where tumour 484 
satellites of single cells occur 1mm away from the site of tumour islands, indicative of 485 
amoeboid/mesenchymal invasion (Brandwein-Gensler et al., 2005). 486 
To conclude, we demonstrate that CRB3b promotes the formation of functional TJs in 487 
a FBM-dependent manner. Further we show that ezrin interacts with the FBM of CRB3b. 488 
These findings further elucidate the mechanism of TJ formation, implicating ezrin in a 489 
process that is independent or parallel to CRB3-PALS1-PATJ complex function. In addition, 490 
in contrast to CRB3a, reduced CRB3b expression correlates with high cytoplasmic ezrin in 491 
HNSCC and further investigation of CRB3b as a potential prognostic marker in HNSCC is 492 
warranted in conjunction with cytoplasmic ezrin. 493 
Materials and Methods 494 
 495 
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Cell culture 496 
MCF10A cells were maintained as previously described (Moleirinho et al., 2013a). EPH4 497 
cells were maintained as previously described (Montesano et al., 1998). CACO-2 cells were 498 
maintained as previously described (Natoli et al., 2012). All cultures were maintained at 37°C 499 
in 5% CO2. 500 
 501 
Retroviral and Lentiviral Plasmids 502 
The FLAG tag was incorporated in to the full length and truncated CRB3b constructs by the 503 
use of the reverse primer 5’-CCCCGAATTCCTACTTGTCATCGTCATCCTTGTAATCGA 504 
TGGGCAGGCAGCCCTG-3’. For pBabe plasmids, the respective inserts were cloned into 505 
the BamHI and EcoRI sites. pBabe plasmids were packaged in PhoenixA cells for viral 506 
production and retroviral infection of MCF10A and EPH4 cells was performed according to 507 
standard protocols. Puromycin selection (2 ug/ml) or hygromycin selection (300 ug/ml) was 508 
applied 48 h after retroviral infection and continued for 5 days (puromycin) or 8 days 509 
(hygromycin), after which cells were harvested or used for further experiments. For shRNA 510 
plasmids, the following oligonucleotid s were synthesized and cloned into AgeI and EcoRI 511 
sites of pLKO.1 puro (Addgene; plasmid 8453). The shRNA duplex hairpin sequences for 512 
mouse Crb3a 5’-TCATCACTACCAACGCCTGG-3’, mouse Crb3b 5’ –513 
TGAGGAGCAGTTTTCCCACG-3’, and human CRB3 5’-514 
GGGCAAATACAGACCACTTCT-3’.  The shRNA duplex hairpin sequence for human 515 
ezrin 5’-GCCTGATTCTCGCGATTAT-3’ has been previously published (Hsu et al., 2012). 516 
A scramble control (shScr) was obtained from Addgene (plasmid 1864). The ViraPower™ 517 
HiPerform™ Promoterless Gateway® Expression System was used in rescue experiments. 518 
The full-length human ezrin cDNA was inserted into Gateway® pENTR™ 11 Dual Selection 519 
Vector and recombined in to pLenti6.4⁄R4R2⁄V5-DEST according to manufacturers 520 
instructions create the ezrin rescue construct pLenti6.4/EF-1α/ezrin (ezrin). pLenti6.4/CMV 521 
V5-MSGW/lacZ was used as the control for the rescue experiments (CTR). pLenti6.4 522 
constructs were packaged in HEK293FT cells. The lentiviral supernatant was added to 523 
MCF10A-CRB3b-shezrin cells. Blasticidin selection was (3.5ug/ml) was applied 48 h after 524 
retroviral infection and continued for 15 days after which cells were harvested or used for 525 
further experiments. All constructs were verified by sequencing 526 
 527 
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RNA isolation and quantitative real time PCR 528 
Isolation of RNA from cell pellets was carried out using an RNeasy Mini Kit. First Strand 529 
cDNA Synthesis Kit for RT-PCR (AMV) was used to synthesize cDNA from 1µg of the 530 
DNase-digested RNA. Relative qPCR was performed using Brilliant III Ultra-Fast SYBR® 531 
Green QPCR Master Mix on a Rotor-GeneQ. All samples were normalized to β-actin and 532 
fold change between samples was calculated using the comparative C(T) method. qPCR 533 
experiments were performed in triplicate from 3 biological replicates. Statistics were 534 
calculated on results from 3-6 runs using GraphPad Prism data software (GraphPad version 535 
5.0b). Absolute qRT-PCR was performed using a one-step RT-PCR using Brilliant III 536 
Ultra-Fast QRT-PCR Master Mix on a Rotor-GeneQ. A standard curve generated 537 
using either Stratagene QPCR Human Reference Total RNA or Stratagene QPCR 538 
Mouse Reference Total RNA was run along side unknown RNA samples.  qRT-PCR 539 
experiments were performed in triplicate from 3 biological replicates. Information 540 
about the standard curves and primer efficiencies from the absolute qPCR is listed in 541 
Supplementary Figure S4.   Primers used for qRT-PCR are listed in Supplementary table 542 
S1. 543 
 544 
Transepithelial electrical resistance measurements 545 
MCF10A, EPH4 and CACO-2 cells were seeded at 2x10
5
 per well onto Millicell 24-well Cell 546 
Culture Assembly plates and readings recorded at regular intervals using a Millicell-ERS 547 
according to the manufacturer’s instructions. Sample readings were measured in triplicate for 548 
each reading. Media was replaced following each reading. 549 
 550 
Size-selective assessment of tight junction paracellular flux 551 
MCF10A, EPH4 and CACO-2 cells were seeded at 2x10
5 
cells per well on polyester 552 
transwell filters (Sigma Aldrich, CLS3460) for 13 days. Media was replaced every 2 days. 553 
Fluorescently labelled dextrans were added to the top well, 25 µl of 4 kDa FITC-Dextran 554 
(Sigma, FD-4) and 25 µl of 70 kDa Rhodamine-Dextran (Sigma, R-9379) and incubated at 555 
37°C for approx. 3 hours. Media from the bottom plate was aliquoted to 3 wells in a black-556 
walled 96-well plate and the following wavelengths; FITC (Exc: 485 nm, Em: 544 nm) and 557 
Rhodamine (Exc: 520 nm, Em: 590 nm) on a FLUOstar microplate reader (Matter and Balda, 558 
2003). The average of the readings were taken as technical replicates and the experiments 559 
were performed in 3 biological repeats. 560 
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 561 
Supplementary Information shows the additional materials and methods. 562 
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 748 
 749 
 750 
 751 
Figure legends 752 
Figure 1. CRB3b induces mature Tight Junctions in MCF10A cells. (A) Schematic diagram 753 
of the different CRB3 intracellular domains and deletion mutants used in this study. CRB3a 754 
with the FERM Binding Motif (FBM) in blue, C-terminal in pink and the PDZ Binding 755 
region in purple. CRB3b showing the FBM in blue and the differing C-terminal in red. FBM 756 
deletion mutants of the CRB3 isoforms, engineered to disrupt CRB3-FERM protein 757 
interactions. (B) Absolute qRT-PCR analysis of the two isoforms of CRB3 in MCF10A cells 758 
shows higher levels of CRB3a mRNA than CRB3b. Error bars represent ±s.d. (n=9). (C) 759 
Immunoblot showing MCF10A-Vector, MCF10A-CRB3a and MCF10A-CRB3a∆FBM 760 
probed with either MYC or V5 antibody for presence of ectopic proteins. β-Actin was used as 761 
a loading control. Immunoblot showing MCF10A-Vector, MCF10A-CRB3b and MCF10A-762 
CRB3b∆FBM probed with FLAG antibody for presence of ectopic proteins. β-Actin was 763 
used as a loading control. (D)MCF10A-Vector, MCF10A-CRB3a, MCF10A-CRB3a∆FBM, 764 
MCF10A-CRB3b and MCF10A-CRB3b∆FBM, cells were grown on 0.4µm PET membranes 765 
and Trans-epithelial Electrical resistance (TER) was recorded. Error bars represent ±s.d 766 
(n=9). Size-selective assessment of tight junction paracellular flux on MCF10A-Vector, 767 
MCF10A-CRB3a, MCF10A-CRB3a∆FBM, MCF10A-CRB3b and MCF10A-CRB3b∆FBM 768 
cells using fluorescently labelled dextrans. Cells were grown for 5 days on 0.4µm PET 769 
membranes prior to addition of fluorescent (E) 4kDa-dextran–FITC and (F) 70kDa-dextran–770 
Rhodamine. Error bars represent ±s.d. (n=9). For all experiments, a two-way ANOVA was 771 
used with Bonferroni correction to compare against MCF10A-Vector. *=p<0.05, 772 
**=p<0.01,*** =p<0.001. 773 
 774 
 775 
Figure 2.  CRB3a and CRB3b are able to promote tight junction formation. (A) 776 
Immunofluorescent confocal imaging of MCF10A-Vector, MCF10A-CRB3a, MCF10A-777 
CRB3a∆FBM, MCF10A-CRB3b and MCF10A-CRB3b∆FBM cells grown for 4 days. 778 
Monolayers were stained for tight junction markers occludin and ZO-1. Scale bar = 10 µm. 779 
(B) The areas completely enclosed by tight junctions were counted. Data is presented as the 780 
mean 5 independent experiments. Error bars represent ±s.d. (n = 5). (C) MCF10A-Vector, 781 
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MCF10A-CRB3a, MCF10A-CRB3a∆FBM, MCF10A-CRB3b and MCF10A-CRB3b∆FBM 782 
cells were cultured in Boyden chambers across a serum gradient for 24hrs and migration was 783 
assessed. Error bars represent ±s.d. (n = 9). For all experiments, a two-way ANOVA was 784 
used with Bonferroni correction to compare against MCF10A-Vector. *=p<0.05, **=p<0.01, 785 
***=p<0.001.  786 
 787 
 788 
Figure 3. Interactions of CRB3b. MCF10A-Vector, MCF10A-CRB3b and MCF10A-789 
CRB3b∆FBM were cultured before being lysed and immunoprecipitation carried out. The 790 
samples were reduced and separated by SDS-PAGE, following which bands were excised 791 
and sent for mass spectrometry analysis. The proteins that bound to the magnetic beads and 792 
CRB3b∆FBM were then removed from list of proteins that bound the full length FLAG-793 
CRB3b. (A) A list of potential interaction partners of CRB3b. (B) IP/Western Blot analysis 794 
of immunoprecipitation reactions involving both the full length CRB3a and the 795 
CRB3a∆FBM, using anti-FLAG, anti-V5, anti-ezrin, anti-willin, anti-merlin and anti-796 
PALS1 antibodies. (C) IP/Western Blot analysis of immunoprecipitation reactions involving 797 
both the full length CRB3b and the CRB3b∆FBM, using anti-FLAG, anti-ezrin, anti-willin, 798 
anti-merlin and anti-importin β1 antibodies.  799 
 800 
 801 
 802 
Figure 4. Depleted ezrin affects the functionality of CRB3b. Rescue of ezrin is able to restore 803 
the CRB3b phenotype. Short hairpin RNAs targeting ezrin and a non-targeting scramble 804 
control were expressed in MCF10A-CRB3b cells. (A) MCF10A-CRB3b-shScr, MCF10A-805 
CRB3b-sh ezrin , MCF10A-CRB3b-sh ezrin + CTR, MCF10A-CRB3b-sh ezrin + ezrin and 806 
MCF10A cells were grown on 0.4µm PET membranes for 21 days, and Trans-epithelial 807 
Electrical resistance (TER) was recorded at 4 day intervals. Error bars represent ±s.d (n=9). A 808 
two-way ANOVA was used to measure significance against MCF10A-CRB3b-sh ezrin cells. 809 
*=p<0.05, **** =p<0.0001. (B) Immunoblot showing MCF10A-CRB3b-shScr and 810 
MCF10A-CRB3b-sh ezrin cells probed with an ezrin antibody to show levels of ezrin 811 
expression. Immunoblot showing MCF10A- MCF10A-CRB3b-sh ezrin + CTR and 812 
MCF10A-CRB3b-sh ezrin + ezrin cells probed with FLAG antibody to show levels of 813 
protein expression.  β-Actin was used as a loading control. Size-selective assessment of tight 814 
junction paracellular flux on MCF10A-CRB3b-shScr, MCF10A-CRB3b-sh ezrin, MCF10A-815 
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CRB3b-sh ezrin + CTR, MCF10A-CRB3b-sh ezrin + ezrin cells using fluorescently labelled 816 
dextrans. Cells were grown for 5 days on 0.4µm PET membranes prior to addition of 817 
fluorescent (C) 4kDa-dextran–FITC and (D) 70kDa-dextran–Rhodamine. Error bars represent 818 
±s.d (n=9). A student’s test was used. ***=p<0.001. (E) Immunofluorescent confocal 819 
imaging of MCF10A-CRB3b-shScr, MCF10A-CRB3b-sh ezrin , MCF10A-CRB3b-sh ezrin 820 
+ CTR, MCF10A-CRB3b-sh ezrin + ezrin cells grown for 4 days. Monolayers were stained 821 
for tight junction markers Occludin and ZO-1. Scale bar = 10 µm. 822 
 823 
 824 
Figure 5. The knockdown of CRB3 affects TJ behaviour. (A and G) Absolute qRT-PCR 825 
analysis of the endogenous levels of the two isoforms of CRB3 in: (A) EPH4 and (G) CACO-826 
2 cells. Error bars represent ±s.d (n=9). (B and H) Relative qPCR analysis of CRB3a in :(B) 827 
EPH4-shScr and EPH4-shCrb3, (H) CACO-2-shScr and CACO-2-shCRB3 cells. β-Actin was 828 
used to normalize for variations in input cDNA. Error bars represent ±s.d (n=9). (C and I)  829 
Relative qPCR analysis of CRB3b in :(C) EPH4-shScr and EPH4-shCrb3, (I) CACO-2-shScr 830 
and CACO-2-shCRB3 cells. β-Actin was used to normalize for variations in input cDNA. 831 
Error bars represent ±s.d (n=9). (D and J) Trans-epithelial Electrical resistance (TER) was 832 
recorded from cells grown on 0.4µm PET membranes from: (D) EPH4-shScr and EPH4-833 
shCrb3, (J) CACO-2-shScr and CACO-2-shCRB3. Error bars represent ±s.d (n=9). (E,F,K 834 
and L) Size-selective assessment of tight junction paracellular flux on EPH4-shScr and 835 
EPH4-shCrb3 cells using fluorescently labelled dextrans (E) 4kDa-dextran–FITC and (F) 836 
70kDa-dextran–Rhodamine. Size-selective assessment of t ght junction paracellular flux on 837 
CACO-2-shScr and CACO-2-shCRB3 cells using fluorescently labelled dextrans. (K) 4kDa-838 
dextran–FITC and (L) 70kDa-dextran–Rhodamine. Error bars represent ±s.d (n=9).  For all 839 
experiments, a student’s test was used. *=p<0.05, **=p<0.01, ***=p<0.001.  840 
  841 
 842 
 843 
Figure 6. CRB3 suppresses migration in EPH4 cells. A) Immunofluorescent confocal 844 
imaging of EPH4-shScr and EPH4-shCrb3 cells grown on glass cover slips. Monolayers were 845 
stained for tight junction marker, ZO-1. Scale bar = 10 µm. (B) The areas completely 846 
enclosed by tight junctions were counted. Data is presented as the mean 5 independent 847 
experiments. Error bars represent ±s.d. (n = 5). (C) Wound closure ability of stable cells was 848 
assessed by a wound-healing assay. Error bars represent ±s.d. (n = 9). (D) EPH4-shScr and 849 
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EPH4-shCrb3 cells were cultured in Boyden chambers across a serum gradient for 24hrs and 850 
migration was assessed. Error bars represent ±s.d. (n = 9).  For all experiments, a student’s 851 
test was used. *=p<0.05, ***=p<0.001.  852 
 853 
Figure 7. CRB3 affects the localization of ezrin. A) Immunofluorescent confocal imaging of 854 
EPH4-shScr and EPH4-shCrb3 cells grown on glass cover slips. Cell monolayers were 855 
assessed for expression of endogenous ezrin. Scale bar = 10 µm. (B) The right panels show 856 
line scan intensity profiles of ezrin across cell boundaries from a line drawn between the 857 
nuclei of adjacent cells. Enrichment at the cell border is seen as a tall spike in the scan 858 
profile. Tracings from 6 cells are shown. (C) Expression of CRB3b and ezrin in squamous 859 
cell carcinoma and normal adjacent squamous epithelium (n=25), as assessed by IHC and 860 
DAB detection. Three representative cases (i, ii, iii) showing images of normal squamous 861 
epithelium (x40 objective magnification); either detecting expression of CRB3b (a(i), a, 862 
a(iii)), or ezrin (b(i), b, b(iii)) and images of squamous cell carcinoma (x40 objective 863 
magnification); either detecting expression of CRB3b (c(i), c, c(iii)), or ezrin (d(i), d, d(iii)). 864 
A white asterisk (*) denotes the stratum spinosum while the blackened arrowhead denotes the 865 
stratum basale. Scale bar = 50 µm. 866 
 867 
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Figure 8. High CRB3b improves high cytoplasmic ezrin survival prediction in HNSCC. 868 
(A) Differences in cancer survival probabilities are shown in the above Kaplan-Meier 869 
plots grouping HNSCC patients by tumour CRB3 isoform precursor RNA or 870 
cytoplasmic ezrin protein expression status alone. Whereas poorer cancer survival was 871 
seen for HNSCC patients with low CRB3b RNA or high cytoplasmic ezrin protein 872 
expression, this was significant only for CRB3b expression (ILMN_1723092 log-rank 873 
p=0.04; Figure A(i)), but not for CRB3ab (ILMN_2405680 p=0.06; Figure A(ii)) or 874 
cytoplasmic ezrin expression (p=0.25; Figure A(iv)), while no association was seen for 875 
CRB3a expression alone (ILMN_1793932 p=0.88; Figure A(iii)). (B) Differences in 876 
cancer survival probabilities are shown in the above Kaplan-Meier plots grouping 877 
HNSCC patients by combined CRB3 and cytoplasmic ezrin protein expression defined 878 
using median cut-off levels in (i) CRB3b (ILMN_1723092), (ii) CRB3ab 879 
(ILMN_2405680), and (iii) CRB3a (ILMN_1793932) isoform precursor RNA expression 880 
in the tumour. Compared to HNSCC patients with either high CRB3 or low cytoplasmic 881 
ezrin expression (i.e., combined as one group), HNSCC patients with low tumour 882 
CRB3b RNA and high cytoplasmic ezrin protein expression had significantly poorer 883 
cancer survival for both CRB3b variant probes (ILMN_1723092 log-rank p=0.04, and 884 
ILMN_2405680 p=0.03) but for not CRB3a (ILMN_1793932 p=0.45). 885 
 886 
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Supplementary information 
 
 
Materials and Methods 
Immunoprecipitation  
MCF10A cells expressing either the empty vector, CRB3b or the CRB3b∆FBM were 
grown on 10cm
2
 plates. The cells were lysed in lysis buffer (50 mM Tris HCl, pH 7.4, 
with 150 mM NaCl, 1 mM EDTA, and 1% TritonX-100). Immunoprecipitation was 
carried out using anti-FLAG M2 Magnetic Beads (Sigma) according to 
manufacturer’s instructions. The end product was run on NuPAGE® Novex® 4-12% 
Bis-Tris Gels (Life technologies, UK) using NuPAGE® MES SDS Running Buffer 
(Life Technologies, UK). The lanes were cut into gel chunks before analysis on the 
TripleTOF 5600. 
 
Analysis on the TripleTOF 5600 
The gel chunk was excised and cut into 1 mm cubes. These were then subjected to in-
gel digestion, using a ProGest Investigator in-gel digestion robot (Genomic Solutions, 
Ann Arbor, MI) using standard protocols. Briefly the gel cubes were destained by 
washing with acetonitrile and subjected to reduction and alkylation before digestion 
with trypsin at 37°C
1
. The peptides were extracted with 10% formic acid and 
concentrated down to 20 µL using a SpeedVac (ThermoSavant). The peptides were 
then separated on an Acclaim PepMap 100 C18 trap and an Acclaim PepMap RSLC 
C18 column (ThermoFisher Scientific), using a nanoLC Ultra 2D plus loading pump 
and nanoLC as-2 autosampler (Eskigent). The peptides were eluted with a gradient of 
increasing acetonitrile, containing 0.1 % formic acid (5-50% acetonitrile in 30 min, 
50-95% in a further 1 min, followed by 95% acetonitrile to clean the column, before 
reequilibration to 5% acetonitrile). The MS/MS data file generated via the ‘Create 
mgf file’ script in PeakView (ABSciex) was analysed using the Mascot algorithm 
(Matrix Science), initially against the NCBInr database Aug 2013 with no species 
restriction, trypsin as the cleavage enzyme and carbamidomethyl as a fixed 
modification of cysteines and methionine oxidation and deamidation of glutamines 
and asparagines as a variable modifications, to confirm protein identification.  
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Western blot analysis 
Cells were lysed in 10 mM Tris (pH 8.0), 150 mM NaCl, 1% Na deoxycholate, 1% 
Nonidet P-40, 1% sodium dodecyl sulphate, 1 mM ethylenediaminetetracetic acid and 
protease inhibitor. Proteins were separated by SDS-PAGE gel electrophoresis gel and 
the lanes were equally loaded with total protein. The proteins were then transferred 
onto PVDF membrane (GE Healthcare, Amersham, UK), protein expression was 
detected by specific antibodies. Primary antibodies used were: ezrin 3C12 
(Neomarkers, USA), Importin β1 [#8673] (Cell Signalling, USA), Merlin [ab88457] 
(Abcam, UK), FRMD6/Willin [EPR12261] (Abcam, UK), FLAG and β-actin (Sigma-
Aldrich). Secondary antibodies used were anti-mouse horseradish peroxidase and 
anti-rabbit horseradish peroxidase (Jackson ImmunoResearch Laboratories, Inc., 
USA). Protein expressions on immunoblots were analyzed using ImageJ analysis and 
a Student’s unpaired t-test was performed to test significance.  
 
Immunohistochemistry 
Tissue samples were obtained from patients undergoing treatment for histologically 
confirmed HNSCC at Montefiore Medical Center in Bronx, NY. All patients provided 
written consent for participation in this study under a protocol approved by the 
Institutional Review Board at Montefiore Medical Center. Slides were dewaxed in 
Xylene 3 times, for 5 mins each, followed by sequential rehydration twice in 100% 
ethanol, 80% ethanol, 50% ethanol for 2 mins after which they were washed in 
running water for 2 mins. Slides were pre-treated with 0.3% H2O2 for 10 min and 
washed in PBS with 1%Tween 20 (PBS/T). Antigen retrieval was performed using 
pH 6.0 10 mM sodium citrate buffer in a steamer for 20 min, then cooled for 30 min 
at RT. Slides were blocked in protein block (DAKO X0909) for 1 h at RT before 
incubating with the following antibodies: ezrin (1/100, Neomarkers, 3C12), CRB3b 
(1/100, Proteintech, 12315-1-AP) overnight at 4C diluted in antibody dilutent 
(DAKO, S0809). Slides were washed 4 times, 5 min each with PBS/T before using 
Peroxidase labelled polymer conjugated to goat anti-mouse (DAKO, K4000) or 
Peroxidase labelled polymer conjugated to goat anti-rabbit (DAKO, K4002) at 1/500 
for 1 h at RT. Slides were washed 3 times, for 10 mins each with PBS/T.  Slides were 
then threated with freshly prepared DAB (DAKO, K3467) applied for 3.5 min 
(CRB3b) and 1.5 min (ezrin). The slides were washed with running water for 2 mins 
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and stained with haematoxylin and washed under running water for 2 mins. The slides 
were dehydrated in 50% ethanol, 80% ethanol, for 30sec each, twice in 100% ethanol, 
for 2 mins each and in Xylene 3 times for 5 mins each. The slide were mounted and 
imaged for analysis. 
 
In vitro wound healing assay 
Stable pools of infected cells were seeded at 8x10
5
 per well (6-well plates) and 
allowed to grow until they reached confluency. Monolayers of confluent cultures 
were gently scratched with a sterile micropipette tip and migration towards the wound 
was monitored at different time points. Phase-contrast images were captured after the 
scratch for each one of the time points. The percentage of scratch covered was 
measured by quantifying the total distance the cells moved from the edge of the 
scratch to complete closure the scratch, using Image J software and MiToBo 
algorithms. Data is presented as the mean percentage of scratch covered in nine 
independent experiments.  
 
Migration Assay using Boyden Chamber 
Serum-free cell suspension (4 x 10
5 
EPH4 cells) were added to the top chamber of 24-
well chambers with 8.0 µm pores (BD Biosciences) and complete media 
supplemented with 20% serum, was added to the lower chamber. MCF10A assay 
media cell suspension (5 x 10
5
 MCF10A cells,) were added to the top chamber of 24-
well chambers with 8.0 µm pores (BD Biosciences) and assay media supplemented 
with 20% serum, was added to the lower chamber. Cells were incubated for 24h at 
37ºC in a humidified atmosphere of 5% (v/v) CO2. After 24h, the top of the insert 
membrane was scrubbed free of cells by using a cotton swab and three PBS washes. 
The bottom side was stained with 0.3% crystal violet (Sigma-Aldrich) in 80% PBS/ 
20% ethanol solution previously filtered through a sterile 0.22µm syringe driven filter 
(Elkay). The number of cells on the lower surface of each chamber was counted using 
a Zeiss Axiovert 40CFL microscope and representative images of migration Boyden 
chambers taken when indicated. 
Quantification of tight junction formation 
 To allow for the quantification of TJs, we defined a TJ structure as a completely 
enclosed ring of smooth, contiguous, apical ZO-1 staining. Cells were immunostained 
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for ZO-1 and examined with a microscope. For each cell sample, the number of tight 
junction structures were counted in six different fields under 20 × magnification using 
a Leica DM5500b microscope and the mean number of tight junction structures per 
field was determined. Experiments were performed three times and the mean number 
of tight junction structures per field from three independent experiments was 
calculated. Error bars represent s.e.m. 
Immunostaining and Imaging 
MCF10A and EPH4 cells were grown on sterile coverslips prior to fixing in 4% 
paraformaldehyde for 15 min at room temperature followed by a 2x5 minute washes 
in PBS. Permeabilization was carried out in 1% NP-40/PBS for 10 minutes. 
Coverslips were washed in PBS before blocking in 3% BSA/PBS for 1 hour at room 
temperature. Samples were incubated with mouse anti-ZO1 (339100, Invitrogen) and 
rabbit anti-occludin (Sigma Aldrich) overnight at 4°C. Coverslips were washed with 
PBS before probing with secondary anti-mouse antibodies conjugated to Dylight488 
and Dylight594 fluorochromes (Jackson ImmunoResearch Laboratories, Inc., USA) 
ProLong Gold Antifade containing DAPI (Invitrogen) was used to visualize nuclei. 
Images were acquired on either a Leica TCS SP8 or on a N-SIM confocal microscope 
(NIKON, Japan).  
 
Global RNA expression 
RNA from tumours was extracted using the same methodology as previously 
described (17).   
 
Statistical analysis 
Statistical differences in cancer survival probabilities were estimated for each CRB3 
probe using Kaplan-Meier analyses and Log-rank tests comparing HNSCC stratified 
by CRB3 alone, defined using median cut-off levels in RNA expression in the tumor, 
as well as by cytoplasmic ezrin status defined assuming a +2 cut-off in protein 
expression level (based on a scale of 0 to 3). Survival was assessed from date of 
diagnosis to death due to HNSCC cancer. Patients who did not die of HNSCC were 
censored at date of death from other causes, or the last recorded follow-up visit they 
were known to be alive.  
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Accession Score Mass
Num. 
of 
matche
s
Num. of 
significant 
matches
Num. of 
sequences
Num. of 
significant 
sequences emPAI
gi|390136349 1721 23876 59 44 9 7 3.4
gi|1127248 1727 23798 57 44 10 7 3.43
gi|11935049 1278 66198 52 41 35 32 5.77
gi|4501885 1148 42052 43 37 19 17 5
gi|422927 869 5952 41 32 3 3 7.58
gi|125786 857 12162 40 31 3 3 2.08
gi|14389309 915 50548 31 28 17 16 2.36
gi|28144893 843 13162 31 26 2 2 2.69
gi|422927 992 5952 29 25 2 2 1.93
gi|28317 584 59720 28 23 20 17 1.97
gi|24987241 475 12798 28 22 1 1 0.31
gi|55956899 818 62255 27 22 16 13 1.53
gi|375314771 660 66184 26 22 19 19 1.82
gi|1297274 662 50941 23 21 12 12 2.1
gi|21961605 667 59020 26 19 23 18 2.01
gi|365813079 474 16080 21 15 10 7 7.7
gi|122920512 603 68408 28 14 9 4 0.3
gi|435476 416 62320 15 13 12 12 1.01
gi|119623932 228 77913 11 9 11 9 0.52
gi|28144893 294 13162 9 9 2 2 1.84
gi|119617035 211 60144 10 7 10 7 0.52
gi|1827928 205 24324 8 7 3 3 0.55
gi|19744484 222 12419 6 6 1 1 0.32
gi|189053456 178 71370 9 6 9 6 0.36
gi|6005814 227 54498 9 6 9 6 0.49
gi|187302 157 27873 7 6 6 5 0.89
gi|98956393 192 5924 7 6 2 1 1.98
gi|62421162 241 11529 7 6 3 3 2.27
gi|22761456 153 32142 7 5 7 5 0.74
gi|20127408 109 83688 6 4 6 4 0.19
gi|5577968 116 40388 7 4 7 4 0.43
gi|54696890 59 28031 6 4 5 3 0.46
gi|225541 94 11002 7 4 5 4 2.45
gi|116063573 62 282581 7 3 6 3 0.04
gi|3282771 79 280185 21 3 5 3 0.04
gi|21749456 97 86111 5 3 4 3 0.13
gi|157830361 169 67988 6 3 6 3 0.17
gi|18999435 136 62568 8 3 7 3 0.19
gi|28940 89 57976 4 3 3 3 0.21
gi|131412225 90 49870 5 3 4 3 0.24
gi|4503529 129 46353 3 3 3 3 0.26
gi|10337595 122 43048 4 3 3 3 0.28
Table S1: This table contains the list of potential interacting partner 
of CRB3b identfied by mass spectrometry.
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gi|28336 83 42128 4 3 4 3 0.29
gi|1617118 95 18486 3 3 2 2 0.46
gi|32532 44 26932 3 3 3 3 0.48
gi|323432500 74 15352 6 3 1 1 0.57
gi|4507357 63 22548 4 3 4 3 0.6
gi|308387374 26 84945 10 2 2 1 0.04
gi|158261055 50 158973 5 2 5 2 0.05
gi|116284341 52 110155 3 2 3 2 0.07
gi|194391174 37 63494 3 2 3 2 0.12
gi|37492 93 50810 3 2 3 2 0.15
gi|119608339 39 51131 4 2 4 2 0.15
gi|30130 71 46352 2 2 2 2 0.17
gi|181914 75 36086 2 2 2 2 0.22
gi|6272654 78 34293 2 2 2 2 0.23
gi|11056044 49 33095 2 2 2 2 0.24
gi|34234 100 31888 2 2 2 2 0.25
gi|28144893 54 13162 2 2 1 1 0.3
gi|3318841 65 25011 3 2 3 2 0.33
gi|2896146 96 24471 2 2 2 2 0.34
gi|1673514 99 23621 4 2 4 2 0.35
gi|32129199 44 23713 2 2 2 2 0.35
gi|13569962 44 22328 3 2 3 2 0.37
gi|5802966 66 18950 2 2 2 2 0.45
gi|119594857 61 15877 2 2 2 2 0.55
gi|4506701 68 15969 2 2 2 2 0.55
gi|485601392 35 14859 3 2 3 2 0.59
gi|189053096 55 14486 4 2 4 2 0.61
gi|7661696 67 13170 2 2 2 2 0.69
gi|453071248 35 12601 9 2 2 2 0.73
gi|5803165 94 10025 2 2 2 2 0.97
gi|21930292 21 245828 7 1 7 1 0.01
gi|515031 14 276915 9 1 3 1 0.01
gi|915392 45 275542 1 1 1 1 0.01
gi|3319326 15 518171 3 1 3 1 0.01
gi|4218955 19 291287 1 1 1 1 0.01
gi|19071209 52 162530 1 1 1 1 0.02
gi|6731237 41 231092 3 1 3 1 0.02
gi|14133239 29 157697 4 1 2 1 0.02
gi|1572721 14 152195 1 1 1 1 0.02
gi|4151328 26 198570 5 1 4 1 0.02
gi|7959223 43 150746 2 1 2 1 0.02
gi|119609716 60 145496 5 1 4 1 0.03
gi|13111995 30 114588 1 1 1 1 0.03
gi|134133226 44 122882 2 1 2 1 0.03
gi|16758920 19 137985 3 1 3 1 0.03
gi|190752 24 108804 2 1 2 1 0.03
gi|36953836 43 142904 4 1 3 1 0.03
gi|3882215 46 120296 2 1 2 1 0.03
gi|117938759 73 111697 2 1 2 1 0.03
gi|220141 22 114517 1 1 1 1 0.03
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gi|23986276 13 145769 4 1 1 1 0.03
gi|119600700 58 125857 3 1 3 1 0.03
gi|13435129 18 130250 1 1 1 1 0.03
gi|5410257 14 114170 3 1 3 1 0.03
gi|194383830 18 82864 3 1 3 1 0.04
gi|2342526 41 85762 1 1 1 1 0.04
gi|762885 22 82381 2 1 2 1 0.04
gi|896473 14 90270 2 1 2 1 0.04
gi|239750 20 96699 4 1 2 1 0.04
gi|27695637 14 99410 2 1 2 1 0.04
gi|15149476 41 76129 2 1 2 1 0.05
gi|194387844 83 69742 5 1 5 1 0.05
gi|31283 55 69470 2 1 2 1 0.05
gi|347134 16 73670 1 1 1 1 0.05
gi|441631513 50 80206 5 1 4 1 0.05
gi|31873994 18 72912 2 1 2 1 0.05
gi|35222 29 71209 1 1 1 1 0.05
gi|4885225 49 68721 1 1 1 1 0.05
gi|1857137 15 70919 3 1 2 1 0.05
gi|42558250 44 78489 1 1 1 1 0.05
gi|3090419 51 58793 1 1 1 1 0.06
gi|3108093 46 65185 1 1 1 1 0.06
gi|4504897 37 58168 1 1 1 1 0.06
gi|6330874 48 65490 2 1 2 1 0.06
gi|35505 18 58411 2 1 2 1 0.06
gi|157830361 43 67988 5 1 3 1 0.06
gi|16549966 23 60793 1 1 1 1 0.06
gi|1478281 69 57041 2 1 2 1 0.07
gi|179930 15 56446 1 1 1 1 0.07
gi|404551426 20 51206 4 1 3 1 0.07
gi|7106439 30 50095 2 1 2 1 0.07
gi|73760405 46 50696 3 1 3 1 0.07
gi|118138656 26 54593 1 1 1 1 0.07
gi|193785970 38 53655 2 1 2 1 0.07
gi|3005677 13 50189 2 1 2 1 0.07
gi|4503445 49 50323 1 1 1 1 0.07
gi|473947 38 50851 2 1 2 1 0.07
gi|340219 63 53738 4 1 3 1 0.07
gi|238828270 13 47324 11 1 6 1 0.08
gi|1526426 16 44418 1 1 1 1 0.08
gi|25955530 39 49151 1 1 1 1 0.08
gi|7661744 39 48360 2 1 2 1 0.08
gi|304766518 31 45734 2 1 2 1 0.08
gi|184462 22 43358 2 1 2 1 0.09
gi|119590453 14 42657 1 1 1 1 0.09
gi|1333632 34 39586 1 1 1 1 0.09
gi|1906670 28 41150 1 1 1 1 0.09
gi|194388786 62 41544 2 1 2 1 0.09
gi|4507869 28 39976 2 1 2 1 0.09
gi|6934244 41 39727 2 1 2 1 0.09
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gi|119621484 14 35862 1 1 1 1 0.1
gi|4758256 22 36374 2 1 2 1 0.1
gi|330689547 15 38775 3 1 1 1 0.1
gi|4502101 46 38918 2 1 2 1 0.1
gi|4503977 45 39211 2 1 2 1 0.1
gi|224036249 44 34345 3 1 3 1 0.11
gi|321117084 44 33177 2 1 2 1 0.11
gi|194373515 34 33856 3 1 3 1 0.11
gi|21754438 64 35373 1 1 1 1 0.11
gi|119575608 27 31446 2 1 2 1 0.12
gi|337451 23 31328 1 1 1 1 0.12
gi|38522 18 31316 3 1 3 1 0.12
gi|119571485 31 30620 3 1 1 1 0.12
gi|119576944 43 31909 2 1 2 1 0.12
gi|31657202 42 32360 2 1 2 1 0.12
gi|158260717 43 30025 2 1 2 1 0.13
gi|5453790 42 30011 1 1 1 1 0.13
gi|951272 52 28463 2 1 2 1 0.13
gi|4507597 19 27427 1 1 1 1 0.14
gi|194385624 16 24937 2 1 2 1 0.15
gi|13129092 58 26194 1 1 1 1 0.15
gi|3318841 38 25011 1 1 1 1 0.15
gi|5114051 65 25329 1 1 1 1 0.15
gi|102863546 47 23182 2 1 1 1 0.16
gi|102863546 45 23182 1 1 1 1 0.16
gi|133778662 56 24210 3 1 2 1 0.16
gi|41472854 20 22259 1 1 1 1 0.17
gi|4502861 45 21946 1 1 1 1 0.17
gi|662841 54 22427 2 1 2 1 0.17
gi|119622718 17 21049 1 1 1 1 0.18
gi|392311671 42 21721 1 1 1 1 0.18
gi|392311671 50 21721 1 1 1 1 0.18
gi|187609338 36 20335 1 1 1 1 0.19
gi|7657441 42 20618 1 1 1 1 0.19
gi|16418397 24 19341 1 1 1 1 0.2
gi|4502981 32 19621 1 1 1 1 0.2
gi|349585158 40 18150 2 1 2 1 0.21
gi|527580 14 18153 1 1 1 1 0.21
gi|119584239 16 18472 1 1 1 1 0.21
gi|54779809 19 17573 1 1 1 1 0.22
gi|4503545 31 17049 1 1 1 1 0.23
gi|4826898 29 15216 1 1 1 1 0.26
gi|6041669 22 15256 1 1 1 1 0.26
gi|388778128 29 13870 4 1 1 1 0.28
gi|58222299 20 13661 1 1 1 1 0.29
gi|315487924 51 12633 1 1 1 1 0.31
gi|270052475 19 12248 1 1 1 1 0.32
gi|2345030 34 12444 2 1 1 1 0.32
gi|270052475 14 12248 1 1 1 1 0.32
gi|19744508 34 12306 1 1 1 1 0.32
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gi|2345030 51 12444 4 1 1 1 0.32
gi|252585 48 11821 1 1 1 1 0.34
gi|38635915 15 11304 1 1 1 1 0.35
gi|4008131 45 10576 1 1 1 1 0.38
gi|4432757 50 9569 1 1 1 1 0.42
gi|1616766 37 9200 1 1 1 1 0.44
gi|190238 25 9246 2 1 2 1 0.44
gi|16075531 55 9224 1 1 1 1 0.44
gi|4758040 39 8776 2 1 2 1 0.46
gi|78101498 27 8004 2 1 2 1 0.51
gi|51036603 77 8115 2 1 2 1 0.51
gi|22000178 15 7720 1 1 1 1 0.53
gi|224278 61 7208 1 1 1 1 0.58
gi|14249376 86 6510 2 1 2 1 0.64
gi|440575891 16 5223 1 1 1 1 0.83
gi|33341236 21 794480 11 1 11 1  
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Description
Chain L, Structure Of Dengue Virus Diii In Complex With Fab 2h12
Chain L, Opg2 Fab Fragment
keratin 1 [Homo sapiens]
actin, cytoplasmic 1 [Homo sapiens]
Ig kappa chain V region - human
RecName: Full=Ig kappa chain V-II region MIL
tubulin alpha-1C chain [Homo sapiens]
protein crumbs homolog 3 isoform b precursor [Homo sapiens]
Ig kappa chain V region - human
unnamed protein product [Homo sapiens]
Chain L, Variable Light Chain Dimer Of Anti-Ferritin Antibody
keratin, type I cytoskeletal 9 [Homo sapiens]
keratin 1 [Homo sapiens]
beta-tubulin [Homo sapiens]
Keratin 10 [Homo sapiens]
Chain A, Crystal Structure Of Human Galectin-3 In Complex With Methyl 2-o- Acetyl-3-o-toluoyl-beta-d-talopyranoside
Chain A, Human Serum Albumin Complexed With Myristate And Aspirin
cytokeratin 9 [Homo sapiens]
heat shock 70kDa protein 1-like [Homo sapiens]
protein crumbs homolog 3 isoform b precursor [Homo sapiens]
keratin 6E, isoform CRA_b [Homo sapiens]
Chain L, Igg Fab (Human Igg1, Kappa) Chimeric Fragment (Cbr96) Complexed With Lewis Y Nonoate Methyl Ester
immunoglobulin light chain variable region [Homo sapiens]
unnamed protein product [Homo sapiens]
serine/threonine-protein kinase 38 [Homo sapiens]
epithelial cell marker protein 1 [Homo sapiens]
immunoglobulin kappa light chain variable region [Homo sapiens]
actin-like protein [Homo sapiens]
unnamed protein product [Homo sapiens]
trifunctional enzyme subunit alpha, mitochondrial precursor [Homo sapiens]
Po66 carbohydrate binding protein 1 [Homo sapiens]
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide [Homo sapiens]
cystic fibrosis antigen
filamin-A isoform 1 [Homo sapiens]
actin-binding protein homolog ABP-278 [Homo sapiens]
unnamed protein product [Homo sapiens]
Chain A, Human Serum Albumin In A Complex With Myristic Acid And Tri- Iodobenzoic Acid
Keratin 5 [Homo sapiens]
unnamed protein product [Homo sapiens]
keratin, type I cytoskeletal 13 isoform a [Homo sapiens]
eukaryotic initiation factor 4A-I isoform 1 [Homo sapiens]
protein phosphatase 1A isoform 1 [Homo sapiens]
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mutant beta-actin (beta'-actin) [Homo sapiens]
TSA [Homo sapiens]
unnamed protein product [Homo sapiens]
immunoglobulin variable region [Homo sapiens]
transgelin-2 isoform b [Homo sapiens]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform PDE4D5 [Homo sapiens]
unnamed protein product [Homo sapiens]
EPRS protein [Homo sapiens]
unnamed protein product [Homo sapiens]
alpha-tubulin [Homo sapiens]
argininosuccinate synthetase, isoform CRA_b [Homo sapiens]
colligin [Homo sapiens]
DNA-binding protein [Homo sapiens]
cytochrome b5 reductase 1 [Homo sapiens]
inorganic pyrophosphatase [Homo sapiens]
laminin-binding protein [Homo sapiens]
protein crumbs homolog 3 is form b precursor [Homo sapiens]
Chain A, Horf6 A Novel Human Peroxidase Enzyme
transcriptional coactivator ALY, partial [Homo sapiens]
B-cell receptor associated protein, partial [Homo sapiens]
SAP domain-containing ribonucleoprotein [Homo sapiens]
ras-related protein Rab-1B [Homo sapiens]
destrin isoform a [Homo sapiens]
cofilin 1 (non-muscle), isoform CRA_c [Homo sapiens]
40S ribosomal protein S23 [Homo sapiens]
Chain M, Structure Of The Human 40s Ribosomal Proteins
unnamed protein product [Homo sapiens]
protein FAM32A [Homo sapiens]
immunoglobulin kappa light chain variable region, partial [Homo sapiens]
protein transport protein Sec61 subunit beta [Homo sapiens]
ninein [Homo sapiens]
protein-tyrosine-phosphatase [Homo sapiens]
fatty acid synthase [Homo sapiens]
protein associated with Myc [Homo sapiens]
gamma-filamin [Homo sapiens]
CD109 [Homo sapiens]
myoferlin [Homo sapiens]
KIAA1121 protein [Homo sapiens]
megakaryocyte stimulating factor [Homo sapiens]
high-risk human papilloma viruses E6 oncoproteins targeted protein E6TP1 alpha [Homo sapiens]
KIAA1481 protein [Homo sapiens]
integrin, beta 4, isoform CRA_e [Homo sapiens]
Ubiquitin associated protein 2-like [Homo sapiens]
POTE ankyrin domain family member E [Homo sapiens]
cullin-associated NEDD8-dissociated protein 1 [Rattus norvegicus]
pemphigus vulgaris antigen [Homo sapiens]
neural interleukin 16 precursor protein [Homo sapiens]
KIAA0747 protein [Homo sapiens]
protein GNAS isoform XLas [Homo sapiens]
VLA-3 alpha subunit [Homo sapiens]
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tripin [Homo sapiens]
hCG1989166, isoform CRA_a [Homo sapiens]
probable cation-transporting ATPase 13A2 isoform 1 [Homo sapiens]
microrchidia [Homo sapiens]
unnamed protein product [Homo sapiens]
IgE autoantigen [Homo sapiens]
Plakoglobin [Homo sapiens]
iron-responsive regulatory protein/iron regulatory protein 1, partial [Homo sapiens]
PML-1=putative zinc finger protein [human, Peptide, 860 aa]
ASXL2 protein [Homo sapiens]
arginine--tRNA ligase, cytoplasmic [Homo sapiens]
unnamed protein product [Homo sapiens]
unnamed protein product [Homo sapiens]
succinate dehydrogenase flavoprotein subunit [Homo sapiens]
PREDICTED: alpha-actinin-4 [Nomascus leucogenys]
hypothetical protein [Homo sapiens]
unnamed protein product [Homo sapiens]
RNA-binding protein EWS isoform 2 [Homo sapiens]
guanylate kinase associated protein [Homo sapiens]
caprin-1 isoform 1 [Homo sapiens]
6-phosphofructo-2-kinase [Homo sapiens]
LIM protein [Homo sapiens]
importin subunit alpha-2 [Homo sapiens]
KIAA1252 protein [Homo sapiens]
pyruvate kinase [Homo sapiens]
Chain A, Human Serum Albumin In A Complex With Myristic Acid And Tri- Iodobenzoic Acid
unnamed protein product [Homo sapiens]
neutral amino acid transporter B [Homo sapiens]
carboxylesterase, partial [Homo sapiens]
immunoglobulin heavy chain, partial [Homo sapiens]
tubulin beta-5 chain [Mus musculus]
thymopoietin isoform beta [Homo sapiens]
Chain A, Structure Of Aminoadipate-Semialdehyde Dehydrogenase
unnamed protein product [Homo sapiens]
testicular tektin B1-like protein [Homo sapiens]
thymidine phosphorylase isoform 1 proprotein [Homo sapiens]
KIAA0115 [Homo sapiens]
vimentin [Homo sapiens]
Chain B, Human Dna Polymerase Iota In Complex With T Template Dna And Incoming Ddadp
proteasome subunit p42 [Homo sapiens]
IL16 protein [Homo sapiens]
basic leucine zipper and W2 domain-containing protein 2 [Homo sapiens]
putative SEC14-like protein 6 [Homo sapiens]
chaperonin-like protein [Homo sapiens]
EDAR-associated death domain, isoform CRA_a [Homo sapiens]
paraoxonase 2 [Homo sapiens]
acyl-CoA thioester hydrolase [Homo sapiens]
unnamed protein product [Homo sapiens]
vasodilator-stimulated phosphoprotein [Homo sapiens]
tropomodulin 3 [Homo sapiens]
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hCG1990311 [Homo sapiens]
eukaryotic translation initiation factor 2 subunit 1 [Homo sapiens]
Chain A, Crystal Structure Of Human Flap Endonuclease Fen1 (Wt) In Complex With Product 5'-Flap Dna, Sm3+, And K+
annexin A1 [Homo sapiens]
starch-binding domain-containing protein 1 [Homo sapiens]
Chain B, Crystal Structure Of The Eif4a-Pdcd4 Complex
RPS10-NUDT3 protein [Homo sapiens]
unnamed protein product [Homo sapiens]
unnamed protein product [Homo sapiens]
signal sequence receptor, alpha (translocon-associated protein alpha), isoform CRA_c [Homo sapiens]
hnRNP type A/B protein [Homo sapiens]
human elongation factor-1-delta [Homo sapiens]
phosphatidylinositol glycan, class S, isoform CRA_b [Homo sapiens]
hCG2043377 [Homo sapiens]
C1orf131 protein, partial [Homo sapiens]
unnamed protein product [Homo sapiens]
nicotinamide N-methyltransferase [Homo sapiens]
keratin like [Homo sapiens]
tumor necrosis factor ligand superfamily member 12 proprotein [Homo sapiens]
unnamed protein product [Homo sapiens]
transmembrane protein 109 precursor [Homo sapiens]
Chain A, Horf6 A Novel Human Peroxidase Enzyme
HSPC029 [Homo sapiens]
MIG7 [Homo sapiens]
MIG7 [Homo sapiens]
immunoglobulin G1 Fab light chain variable region [Homo sapiens]
unknown [Homo sapiens]
AP-3 complex subunit sigma-1 [Homo sapiens]
heat shock protein 27 [Homo sapiens]
TM2 domain containing 3, isoform CRA_a [Homo sapiens]
Chain B, Crystal Structure Of The Dhr-2 Domain Of Dock8 In Complex With Cdc42 (T17n Mutant)
Chain B, Crystal Structure Of The Dhr-2 Domain Of Dock8 In Complex With Cdc42 (T17n Mutant)
Chain A, Crystal Structure Of The Extracellular Portion Of Hab18gCD147
28 kDa heat- and acid-stable phosphoprotein [Homo sapiens]
protein MAL2 [Homo sapiens]
cytochrome c oxidase subunit 4 isoform 1, mitochondrial precursor [Homo sapiens]
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial isoform 2 precursor [Homo sapiens]
ribosomal protein L18a homologue [Homo sapiens]
hCG1794003 [Homo sapiens]
immunoglobulin mu heavy chain [Homo sapiens]
eukaryotic translation initiation factor 5A-1 isoform B [Homo sapiens]
profilin-1 [Homo sapiens]
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 isoform 1 [Homo sapiens]
immunoglobulin heavy chain variable region, partial [Homo sapiens]
anti-tetanus toxoid immunoglobulin heavy chain variable region [Homo sapiens]
immunoglobulin variable region [Homo sapiens]
immunoglobulin heavy chain variable region [Homo sapiens]
Ig kappa light chain variable region [Homo sapiens]
immunoglobulin heavy chain variable region [Homo sapiens]
immunoglobulin light chain variable region [Homo sapiens]
Page 48 of 61
http://mc.manuscriptcentral.com/jmcb
Manuscripts submitted to Journal of Molecular Cell Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Ig kappa light chain variable region [Homo sapiens]
interferon-stimulated gene factor 3 alpha 91/84 kda protein, ISGF3 alpha 91/84 kda protein {SH2 and SH3 domains} [human, Peptide Partial, 102 aa, segment 2 of 2]
unnamed protein product [Homo sapiens]
chaperonin 10 [Homo sapiens]
ribosomal protein P0 [Homo sapiens]
cationic trypsinogen, partial [Homo sapiens]
nucleolar phosphoprotein B23, partial [Homo sapiens]
immunoglobulin kappa chain variable region [Homo sapiens]
cytochrome c oxidase subunit 6C proprotein [Homo sapiens]
Chain A, Crystal Structure Of Kh1 Domain Of Human Poly(C)-Binding Protein-2 With C-Rich Strand Of Human Telomeric Dna
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 precursor [Homo sapiens]
immunoglobulin heavy chain variable region [Homo sapiens]
metallothionein MT IIpg
up-regulated during skeletal muscle growth protein 5 [Homo sapiens]
alternative protein KDM2A [Homo sapiens]
polytrophin [Homo sapiens]
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Chain A, Crystal Structure Of Human Galectin-3 In Complex With Methyl 2-o- Acetyl-3-o-toluoyl-beta-d-talopyranoside
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Chain A, Crystal Structure Of Human Flap Endonuclease Fen1 (Wt) In Complex With Product 5'-Flap Dna, Sm3+, And K+
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial isoform 2 precursor [Homo sapiens]
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interferon-stimulated gene factor 3 alpha 91/84 kda protein, ISGF3 alpha 91/84 kda protein {SH2 and SH3 domains} [human, Peptide Partial, 102 aa, segment 2 of 2]
Chain A, Crystal Structure Of Kh1 Domain Of Human Poly(C)-Binding Protein-2 With C-Rich Strand Of Human Telomeric Dna
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QPCR	  PRIMERS	  hCRB3a	  FW	   GGAAGAGCGGCTCATCTGAA	  hCRB3a	  RV	   GGTGTACAAGCCAGCAACCC	  hCRB3b	  FW	   CCAGTAGCGAGGAGCAGTTC	  hCRB3b	  RV	   GGAGAGGGGACCTAGATGGG	  hACTIN	  FW	   CAGGAAGGAAGGCTGGAAGA	  hACTIN	  RV	   GCTGTGCTATCCCTGTACGC	  mCRB3a	  FW	   GCTCATGCGAAAACTTCGGG	  mCRB3a	  RV	   CCAGGCGTTGGTAGTGATGA	  mCRB3b	  FW	   CCCAGGTGATGAGTCCAACG	  mCRB3b	  RV	   CGTGGGAAAACTGCTCCTCA	  mACTIN	  FW	   GGCTGTATTCCCCTCCATCG	  mACTIN	  RV	   CCAGTTGGTAACAATGCCATGT	  	   	  	   	  	   	  	   	  	   	  	  Table	  S?: This	   table	  shows	  the	  sequences	  of	  primers	  used	  to	  detect	  the	  levels	  of	  endogenous	  CRB3	  isoforms	  in	  human	  and	  mouse	  cell	  lines.	  Primers	  for	  actin	  which	  was	  used	  as	  a	  reference	  gene	  is	  listed.	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Figure S1. (A) Immunofluorescent confocal images of MCF10A-Vector, MCF10A-
CRB3a, and MCF10A-CRB3b cells. Monolayers were stained with anti-Myc to 
detect CRB3a, anti-FLAG to detect CRB3b and anti-Ezrin. Both CRB3a and CRB3b 
localize to the regions of cell-to-cell contacts along with ezrin, which is also 
present at the cell junctions. Images were taken using a Leica SP8 confocal 
microscope at 63X magnification. Scale bar= 10 μm. (B) Immunofluorescent 
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confocal images of MCF10A-Vector, MCF10A-CRB3a, and MCF10A-CRB3b cells. 
Monolayers were stained with anti-Myc to detect CRB3a; anti-FLAG to detect 
CRB3b. CRB3a localizes in the cytoplasm and cell junctions and is excluded from 
the nucleus. CRB3b localizes in the cytoplasm, cell junctions and in the nucleus. 
Images were taken using a Leica SP8 confocal microscope at 40X magnification. 
Scale bar= 20 μm. 
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Figure S2. Quantitative real-time PCR analysis of the levels of the two isoforms of 
Crb3 in EPH4 cells. β-Actin was used to normalize for variations in input cDNA. 
Error bars represent ±s.d (n=9). For all experiments, a student’s test was used. 
*=p<0.05, ***=p<0.001. (A) The relative levels of Crb3a in EPH4-ShSCR, EPH4-
ShCrb3a and EPH4-ShCrb3b. (B) The relative levels of Crb3b in EPH4-ShSCR, 
EPH4-ShCrb3a and EPH4-ShCrb3b. (C) EPH4 sh scr, EPH4 sh Crb3a, EPH4 sh 
Crb3b cells and EPH4 sh Crb3 cells were grown on 0.4 μm PET membranes for 
29 days, and TER was recorded at 4 day intervals. Error bars represent ±s.d 
(n=6). A two-way ANOVA was used with Bonferroni post-tests to compare 
against EPH4 sh scr,  *=P<0.05, *** =P<0.001, **** =P<0.0001. (D) Size-selective 
assessment of TJ paracellular flux on EPH4 sh scr, EPH4 sh Crb3a, EPH4 sh Crb3b 
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cells and EPH4 sh Crb3 cells using fluorescently labelled dextrans. Cells were 
grown for 5 days on 0.4 μm PET membranes prior to addition of fluorescent 4 
kDa-dextran–FITC. Error bars represent ±s.d (n=6). A two-way ANOVA was used 
with Bonferroni post-tests to compare against EPH4 sh scr,  **=P<0.01, *** 
=P<0.001. (E) Size-selective assessment of TJ paracellular flux on EPH4 sh scr, 
EPH4 sh Crb3a, EPH4 sh Crb3b cells and EPH4 sh  Crb3 cells using fluorescently 
labelled dextrans. Cells were grown for 5 days on 0.4 μm PET membranes prior 
to addition of fluorescent  70 kDa-dextran–Rhodamine. Error bars represent ±s.d 
(n=6). A two-way ANOVA was used with Bonferroni correction to compare 
against EPH4 sh scr,  **=P<0.01, *** =P<0.001.  
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Figure S3. To show the specificity of the CRB3 antibody used for the detection of 
CRB3b in normal and tumour tissue. (A) Using HEK293 cells that have been 
transiently transfected with the empty pBabe Vector, untagged CRB3a or 
untagged CRB3b. MCF10A stably expressing CRB3b.FLAG was used as a positive 
control and the blot was probed for β actin as a loading control. (B) MCF10A 
stably expressing the empty pBabe Vector, untagged CRB3a or untagged CRB3b 
was probed using a antibody for CRB3b. The MCF10a expressing CRB3b isoform 
was detected indicating the specificity of the antibody for CRB3b.    
HEK 293 
Vector CRB3b CRB3a MCF10A RB3b.LG CRB3bCRB3aVector
MCF10A
α CRB3B 
α β ACTIN
A B
α FLAG
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Figure S4. The standard curves plotted with the Ct values against the log quantity 
of the amount of RNA used for the absolute quantification of human (A) CRB3a 
and (B) CRB3b and mouse (C) Crb3a and (D) Crb3b isoforms. The standard 
curves were performed along side unknown samples for every qPCR experiment. 
(E) The primer efficiency percentage for each primer pair was calculated based 
on the slope of the standard curve where efficiency =((10-1/slope)-1).  
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A B 
C D 
E 
Organism Isoform Slope  Efficiency R2 
Human 
CRB3a -3.2495 103.11 0.996 
CRB3b -3.2147 104.68 0.965 
Mouse 
Crb3a -3.3797 97.64 0.962 
Crb3b -3.2410 103.49 0.983 
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